e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Diagnosis and management of respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Phenotypic comparison of glucose and cardiac physiology of biomass fuel induced and smoking induced COPD
S. Rafiei, M. Kulkarni, S. Naik, J. Londhe, N. Iyer, S. Madas, P. Barnes, S. Salvi, B. Brashier (Pune, India; London, United Kingdom)
Source:
Annual Congress 2013 –Diagnosis and management of respiratory diseases
Session:
Diagnosis and management of respiratory diseases
Session type:
Thematic Poster Session
Number:
4172
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Rafiei, M. Kulkarni, S. Naik, J. Londhe, N. Iyer, S. Madas, P. Barnes, S. Salvi, B. Brashier (Pune, India; London, United Kingdom). Phenotypic comparison of glucose and cardiac physiology of biomass fuel induced and smoking induced COPD. Eur Respir J 2013; 42: Suppl. 57, 4172
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Corticosteroids improve lung function and quality of life in subjects with biomass fuel (BMF) smoke exposures induced COPD
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Comparison of airway cellular and mediator profiles between tobacco smoke-induced COPD and biomass fuel exposure-induced COPD in an Indian population
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
Effect of exercise challenge on systemic inflammatory markers in healthy smokers and smokers with COPD
Source: International Congress 2014 – Mechanisms of exercise limitation in health and disease
Year: 2014
The influence of hyperinflation on body composition and cytokine profile in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Correlation between heart rate variability indexes and aerobic physiological variables in patients with COPD
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment methods in COPD and asthma
Year: 2013
Fructosamine-3-Kinase: A molecular link between COPD and diabetes regulating carbonyl stress and the impact of metformin treatment
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Prediction of exercise capacity using impulse oscillation system in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
High prevalence of altered cardiac repolarization in patients with COPD
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Metabolic regulation during the co-existence of COPD and DM type2
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Inhaled beta-agonist does not modify sympathetic activity in patients with COPD
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Longitudinal change in peak oxygen uptake in COPD patients
Source: International Congress 2014 – Clinical exercise physiology in health and COPD
Year: 2014
The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Correlation between extracellular heat shock protein 72 and clinical parameters including exhaled oxygen level in COPD
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Comorbidities impair physical activity in COPD irrespective of airflow limitation
Source: International Congress 2014 – Comorbidities
Year: 2014
Morphological markers of resistance bronchial mucosa of smokers to the development of COPD
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Comparative study of respiratory symptoms, lung function, BMI and exercise capacity in patients with COPD associated with tobacco smoke (TS) and biomass smoke (BS) exposure
Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care
Year: 2012
Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures
Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept